Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immucell (ICCC) Long-Term Investments (2016 - 2019)

Immucell's Long-Term Investments history spans 6 years, with the latest figure at $4117.0 for Q1 2019.

  • For Q1 2019, Long-Term Investments fell 95.69% year-over-year to $4117.0; the TTM value through Mar 2019 reached $4117.0, down 95.69%, while the annual FY2018 figure was $40209.0, 57.92% down from the prior year.
  • Long-Term Investments reached $4117.0 in Q1 2019 per ICCC's latest filing, down from $40209.0 in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $489648.0 in Q4 2015 to a low of $4117.0 in Q1 2019.
  • Average Long-Term Investments over 5 years is $236376.1, with a median of $96973.5 recorded in 2017.
  • Peak YoY movement for Long-Term Investments: fell 1.28% in 2015, then crashed 95.69% in 2019.
  • A 5-year view of Long-Term Investments shows it stood at $489648.0 in 2015, then fell by 0.54% to $487000.0 in 2016, then crashed by 80.38% to $95557.0 in 2017, then plummeted by 57.92% to $40209.0 in 2018, then crashed by 89.76% to $4117.0 in 2019.
  • Per Business Quant, the three most recent readings for ICCC's Long-Term Investments are $4117.0 (Q1 2019), $40209.0 (Q4 2018), and $98390.0 (Q3 2018).